<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Innate Immunity on Adrian G. Zucco</title>
    <link>http://localhost:1313/tags/innate-immunity/</link>
    <description>Recent content in Innate Immunity on Adrian G. Zucco</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <managingEditor>adrigabzu@sund.ku.dk (Adrian G. Zucco)</managingEditor>
    <webMaster>adrigabzu@sund.ku.dk (Adrian G. Zucco)</webMaster>
    <copyright>MIT License ✨ Made with ❤️ and vibes by Adrian G. Zucco</copyright>
    <lastBuildDate>Thu, 01 Sep 2022 00:00:00 +0000</lastBuildDate><atom:link href="http://localhost:1313/tags/innate-immunity/index.xml" rel="self" type="application/rss+xml" />
    
    <item>
      <title>Early Stimulated Immune Responses Predict Clinical Disease Severity in Hospitalized COVID-19 Patients</title>
      <link>http://localhost:1313/publication/svanbergearlystimulatedimmune2022/</link>
      <pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate>
      <author>adrigabzu@sund.ku.dk (Adrian G. Zucco)</author>
      <guid>http://localhost:1313/publication/svanbergearlystimulatedimmune2022/</guid>
      <description>The immune pathogenesis underlying the diverse clinical course of COVID-19 is poorly understood. Currently, there is an unmet need in daily clinical practice for early biomarkers and improved risk stratification tools to help identify and monitor COVID-19 patients at risk of severe disease.</description>
      
    </item>
    
  </channel>
</rss>
